Promising New Drug Blocks Mutation In Bone Marrow Cancers

Researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers. The oral drug, called CYT387, was tested in mice as well as in human cells. In both cases, it blocked the growth of certain bone marrow cancers called myeloproliferative disorders, also referred to as MPDs.

Read the whole article on Science Daily

More from Science Daily